BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32986090)

  • 1. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease.
    Wang Z; Becker K; Donadio V; Siedlak S; Yuan J; Rezaee M; Incensi A; Kuzkina A; Orrú CD; Tatsuoka C; Liguori R; Gunzler SA; Caughey B; Jimenez-Capdeville ME; Zhu X; Doppler K; Cui L; Chen SG; Ma J; Zou WQ
    JAMA Neurol; 2020 Sep; 78(1):1-11. PubMed ID: 32986090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders.
    Manne S; Kondru N; Hepker M; Jin H; Anantharam V; Lewis M; Huang X; Kanthasamy A; Kanthasamy AG
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):423-435. PubMed ID: 30706414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies.
    Rossi M; Candelise N; Baiardi S; Capellari S; Giannini G; Orrù CD; Antelmi E; Mammana A; Hughson AG; Calandra-Buonaura G; Ladogana A; Plazzi G; Cortelli P; Caughey B; Parchi P
    Acta Neuropathol; 2020 Jul; 140(1):49-62. PubMed ID: 32342188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
    Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
    Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The promise of amplification assays for accurate early detection of α-synucleinopathies: A review.
    Kurapova R; Chouliaras L; O'Brien JT
    Exp Gerontol; 2022 Aug; 165():111842. PubMed ID: 35623540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.
    Luan M; Sun Y; Chen J; Jiang Y; Li F; Wei L; Sun W; Ma J; Song L; Liu J; Liu B; Pei Y; Wang Z; Zhu L; Deng J
    Mov Disord; 2022 May; 37(5):1059-1063. PubMed ID: 35278004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy.
    De Luca CMG; Elia AE; Portaleone SM; Cazzaniga FA; Rossi M; Bistaffa E; De Cecco E; Narkiewicz J; Salzano G; Carletta O; Romito L; Devigili G; Soliveri P; Tiraboschi P; Legname G; Tagliavini F; Eleopra R; Giaccone G; Moda F
    Transl Neurodegener; 2019; 8():24. PubMed ID: 31406572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Donadio V; Wang Z; Incensi A; Rizzo G; Fileccia E; Vacchiano V; Capellari S; Magnani M; Scaglione C; Stanzani Maserati M; Avoni P; Liguori R; Zou W
    Neurology; 2021 May; 96(20):e2513-e2524. PubMed ID: 33837116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein.
    Srivastava A; Alam P; Caughey B
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
    Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
    Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson's disease.
    Shin C; Han JY; Kim SI; Park SH; Yang HK; Lee HJ; Kong SH; Suh YS; Kim HJ; Choi YP; Jeon B
    Parkinsonism Relat Disord; 2022 Oct; 103():23-28. PubMed ID: 36029607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
    Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
    Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.
    Iranzo A; Mammana A; Muñoz-Lopetegi A; Dellavalle S; Mayà G; Rossi M; Serradell M; Baiardi S; Arqueros A; Quadalti C; Perissinotti A; Ruggeri E; Cano JS; Gaig C; Parchi P
    Neurology; 2023 May; 100(18):e1944-e1954. PubMed ID: 36931726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streamlined alpha-synuclein RT-QuIC assay for various biospecimens in Parkinson's disease and dementia with Lewy bodies.
    Bargar C; Wang W; Gunzler SA; LeFevre A; Wang Z; Lerner AJ; Singh N; Tatsuoka C; Appleby B; Zhu X; Xu R; Haroutunian V; Zou WQ; Ma J; Chen SG
    Acta Neuropathol Commun; 2021 Apr; 9(1):62. PubMed ID: 33827706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
    Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N
    Nat Med; 2023 Jun; 29(6):1448-1455. PubMed ID: 37248302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid-A Systematic Review and Meta-Analysis.
    Grossauer A; Hemicker G; Krismer F; Peball M; Djamshidian A; Poewe W; Seppi K; Heim B
    Mov Disord Clin Pract; 2023 May; 10(5):737-747. PubMed ID: 37205253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis.
    Yoo D; Bang JI; Ahn C; Nyaga VN; Kim YE; Kang MJ; Ahn TB
    Parkinsonism Relat Disord; 2022 Nov; 104():99-109. PubMed ID: 36289019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.
    Paciotti S; Bellomo G; Gatticchi L; Parnetti L
    Front Neurol; 2018; 9():415. PubMed ID: 29928254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.